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Introduction
Parkinson’s disease (PD) is the second most common neuro­
degenerative disease, affecting 1–2% of the population over the 
age of 65 (de Rijk et al., 2000). The majority of PD cases are 
of a sporadic nature with unknown etiology. However, muta­
tions in several genes that result in familial forms of PD have 
been identified. Among them, the PARK7 locus corresponds to 
the gene coding for the DJ­1 protein (Bonifati et al., 2003a).   
Diverse mutations, including deletions and point mutations in 
the DJ-1 gene, have been described and were linked to auto­
somal  recessive  early­onset  parkinsonism  (Bonifati  et  al., 
2003b). DJ­1 is a protein of 20 kD whose loss of function is   
hypothesized to constitute the pathological mechanism under­
lying the disease. DJ­1 is widely expressed in neurons and glia as 
well as peripheral tissues (Bandopadhyay et al., 2004; Olzmann   
et al., 2007). It was found to be localized in the cytosol and the 
nucleus, with a small fraction being associated with mitochondria 
(Zhang et al., 2005; Junn et al., 2009). Different functions have 
been suggested for DJ­1, including characterization as a redox 
sensor (Kinumi et al., 2004; Taira et al., 2004; Andres­Mateos   
et al., 2007; Batelli et al., 2008), a molecular chaperone (Xia   
et al., 2003; Olzmann et al., 2004), or a transcriptional cofactor 
(Bae et al., 2005). The association of DJ­1 with HSP70 (heat 
shock protein 70) and other molecular chaperones was described 
previously (Li et al., 2005). The crystal structure of DJ­1 in­
dicated that the protein forms a homodimer in vitro (Honbou 
et al., 2003; Wilson et al., 2003). Interestingly, the most com­
monly studied DJ­1 L166P mutation appears to be impaired in 
dimer formation (Moore et al., 2003; Blackinton et al., 2005), 
suggesting that dimer formation is required for its physiological 
function. Some groups have shown that L166P is unstable in 
mammalian cells, implicating a faster turnover of the mutated 
protein by degradation via the proteasome system and nonprotea­
somal pathways (Miller et al., 2003; Moore et al., 2003; Görner 
et al., 2004; Olzmann et al., 2004).
BAG1  (Bcl­2–associated  athanogene  1)  is  a  cochaper­
one of HSP70 that stimulates its ATPase­ and protein­folding   
activity (Takayama et al., 1997; Sondermann et al., 2001; 
Liman et al., 2005). BAG1 also binds to the proteasome, where 
it is believed to act as a shuttle protein, delivering chaperone­ 
recognized misfolded substrates to the proteasome for degra­
dation (Lüders et al., 2000; Demand et al., 2001). BAG1 is of 
particular significance for the nervous system. It was described 
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As expected, we were able to detect endogenous HSP70 
as a second interacting protein of Flag­BAG1. In line with a 
previous study (Kermer et al., 2003), expression levels of HSP70 
were slightly increased in the case of BAG1 overexpression. 
The deletion mutant Flag­BAGC did not show an interaction 
with either HSP70 or DJ­1 (Fig. 1). Next, we performed the ex­
periment with coimmunoprecipitation of BAG1 via Flag–DJ­1 
constructs. Again, a strong interaction between DJ­1 and BAG1 
could be observed, and HSP70 was also detected as a second 
interacting protein for the L166P mutant protein (Fig. 2).
We  then  performed  subcellular  fractionation  into  cyto­
solic, membranous/organellar, nuclear, and cytoskeletal fractions. 
Both DJ­1 wild type and L166P were found equally abundant in 
the cytosolic and membrane/organelle fractions (Fig. 3 A). 
However, the nuclear fraction contained only mutant DJ­1, 
whereas DJ­1 wild type was absent. Coexpression of BAG1 to­
gether with L166P DJ­1 decreased its amount in the nucleus, as 
shown by subcellular fractionation. Results were confirmed in situ 
using EGFP­tagged DJ­1. The nuclear accumulation of L166P 
mutant contrasted with the absence of nuclear staining of DJ­1 
wild type (Fig. 3 B).
On immunoblots, in addition to a band running at 25 kD 
that corresponds to monomeric DJ­1, we could detect a band at 
50 kD, which presumably corresponds to DJ­1 homodimers. This 
band was particularly strong in the membrane/organelle fraction. 
Coexpression of BAG1 together with DJ­1 significantly increased 
to stimulate neuronal differentiation and to promote neuronal 
survival (Kermer et al., 2002; Liman et al., 2008). Mice lacking 
BAG1 die embryonically as a result of apoptosis in the nervous 
system and liver (Götz et al., 2005). Conversely, overexpression 
of BAG1 provides protection against various apoptotic insults 
(Takayama et al., 1995; Kermer et al., 2003; Townsend et al., 
2003). Moreover, BAG1 proved to enhance axonal regenera­
tion in mice (Planchamp et al., 2008). In this study, we describe 
BAG1 as a DJ­1–interacting protein that has the ability to re­
store DJ­1 L166P function.
Results
BAG1 interacts with DJ-1 and affects its 
dimer formation
Wild­type DJ­1 and DJ­1 L166P mutant were expressed in SH­
SY5Y neuroblastoma cells in the presence or absence of Flag­
BAG1. Coimmunoprecipitation showed that wild­type and mutant 
forms of DJ­1 as well as the endogenous protein interact with 
BAG1. To evaluate the specificity and to examine binding affin­
ity, we included conditions in which the recombinant DJ­1 was 
absent or in which the endogenous DJ­1 protein was knocked 
down using siRNA. As indicated in Fig. 1, we were not able to 
detect a preferential association of BAG1 with either endogenous 
or recombinant DJ­1. At the same time, pull­down signals could 
be extinguished by DJ­1 siRNA.
Figure 1.  BAG1 interacts with recombinantly 
expressed  and  endogenous  DJ-1.  Wild-type   
DJ-1 (DJ-1 WT) and DJ-1 L166P mutant (DJ-1   
Mut)  with  a  V5/HIS  tag  were  transiently 
transfected in SH-SY5Y cells in the presence 
or absence of Flag-BAG1 and Flag-BAGC. 
Knockdown  of  endogenous  DJ-1  was  per-
formed  with  DJ-1  siRNA.  Coimmunoprecipi-
tation (CO-IP) shows the interaction between 
BAG1 and both forms of the DJ-1 protein. In 
addition, endogenous DJ-1 and HSP70 could 
also  be  detected  via  BAG1  pull-down.  The 
BAGC deletion variant failed to interact either 
with DJ-1 or with HSP70. Both siRNA samples 
were  grouped  to  the  figure  from  a  different 
gel. White lines indicate that intervening lanes 
have  been  spliced  out.  WB,  Western  blot. 507 BAG1 restores DJ-1 function • Deeg et al.
dependent YFP (cdYFP) with low fluorescence intensity caused 
by a point mutation that impairs its folding, preventing the for­
mation of the chromophore. The protein is tuned such that an 
increase in chaperone activity corrects its folding defect, giving 
rise to an increase in its fluorescence intensity. We expressed 
cdYFP together with DJ­1 wild type or L166P in neuronal 
CSM 14.1 cells and performed quantitative measurements of 
the fluorescence intensity of cdYFP relative to the Cy5 immuno­
fluorescence signal, which constitutes an inert concentration   
reference to calculate folding activity (expressed as fold increase 
relative to the activity in cells expressing only the cdYFP sensor) 
with high spatiotemporal resolution inside intact cells. Under 
control conditions in which cells expressed cdYFP together with 
an empty vector, we observed a narrow distribution of low YFP 
fluorescence (Fig. 5 A, black trace with grayed area). Expression 
of DJ­1 resulted in a substantial and highly significant increase 
in cellular folding activity, with a median increase of three­
fold, reaching levels up to 8–10­fold (Fig. 5 B, red trace). Cells   
expressing DJ­1 L166P mutant showed a folding activity dis­
tribution that was essentially identical to control cells, indicat­
ing that the mutation completely abolishes foldase activity of   
DJ­1 (Fig. 5 C, red trace). As shown before, expression of 
BAG1 increased the cellular foldase activity up to sixfold as a 
result of the activation of chaperones (Fig. 5 A, green trace; Liman 
et al., 2005). Coexpression of BAG1 together with DJ­1 L166P 
resulted in a dramatic shift toward high folding activities, thus 
restoring DJ­1 chaperone function (Fig. 5 B, dark blue trace). 
These increased folding activity levels exceeded those reached 
by the expression of foldase­stimulating BAG1 alone, showing 
the additional separate activity of DJ­1. The light blue traces in 
Fig. 5 B represent the isolated DJ­1 folding activities, which 
were corrected for the distribution of folding activities generated 
by the direct action of BAG1 for the coexpression conditions. 
As observed for the dimerization behavior of DJ­1 in the pres­
ence of BAG1, the folding activity of DJ­1 wild type was also 
increased by BAG1 (Fig. 5 B, dark blue trace). Importantly,   
folding activity levels reached by BAG1 coexpression with mu­
tant DJ­1 were similar to those in which DJ­1 wild type was co­
expressed together with BAG1 (Fig. 5 C, dark blue trace).
BAG1 prevents DJ-1 L166P–induced  
cell death
To assess the functional relevance of these findings, we cotrans­
fected SH­SY5Y cells with fluorescently tagged DJ­1 (either wild 
type or L166P) and BAG1 or empty vector. Cells expressing DJ­1 
wild type showed a 5% basal cell death rate. Transfection of DJ­1 
L166P mutant led to an increase in the number of dead cells up to 
20%. The toxicity of the DJ­1 mutant was ameliorated by co­
transfection with BAG1, with only 8% of dead cells found under 
this condition. We confirmed these findings by the application of 
an independent bioluminescent cytotoxicity assay that quantifies 
the integrity of the plasma membrane by measurement of the re­
lease of the intracellular enzyme adenylate kinase into the me­
dium. Here, we included expression of the BAGC deletion mutant 
as a condition. The inability of the BAGC deletion mutant to ame­
liorate DJ­1 L166P toxicity (Fig. 6) demonstrated the specificity 
of the cell death–preventing action of the BAG1 cochaperone.
the ratio of dimer/monomer staining intensity both for wild­
type and mutant protein (Fig. 3 C). All results were reproduced 
in the nonneuronal HEK293T cell line (unpublished data).
To further investigate the possibility that BAG1 influences 
the dimerization of DJ­1, we performed Förster resonance energy 
transfer (FRET)/fluorescence lifetime imaging (FLIM) experi­
ments with fluorescently (CFP or YFP) labeled DJ­1. The occur­
rence of FRET between CFP­ and YFP­labeled DJ­1, as judged 
quantitatively by a reduction in the CFP fluorescence lifetime, 
is indicative of its homodimerization. In agreement with the 
fractionation experiments, we observed that the FRET efficiency 
was significantly greater for DJ­1 wild type (25%) than DJ­1 L166P 
(10%). Coexpression of BAG1 together with DJ­1 L166P sub­
stantially increased FRET efficiency of the mutant proteins al­
most to the levels of DJ­1 wild type (Fig. 4, A–D; P < 0.001). 
Interestingly, BAG1 was also able to augment the dimerization 
of DJ­1 wild type.
DJ-1 possesses chaperone activity
Several studies have suggested that DJ­1 might function as a 
molecular chaperone (Shendelman et al., 2004; Li et al., 2005; 
Zhou et al., 2006), but conclusive in situ evidence is still lack­
ing. For this reason, we took advantage of a unique fluorescent 
biosensor for the activity of the cellular chaperone machinery 
(Liman et al., 2005). The sensor consists of a chaperone­
Figure  2.  Immunoprecipitation  of  BAG1  through  DJ-1  wild  type  and 
L166P DJ-1. BAG1 and BAGC were transiently transfected in SH-SY5Y 
cells in the presence or absence of Flag–DJ-1 wild type (DJ-1 WT) and 
Flag–DJ-1 mutant (DJ-1 Mut). Again, coimmunoprecipitation (CO-IP) shows 
the interaction between BAG1 and both forms of the DJ-1 protein. Endog-
enous HSP70 was only detected via pull-down of Flag–DJ-1 mutant. WB, 
Western blot.JCB • VOLUME 188 • NUMBER 4 • 2010   508
Figure 3.  BAG1 influences DJ-1 dimerization and subcellular localization. (A) Wild-type DJ-1 (DJ-1 WT) and DJ-1 L166P mutant (DJ-1 Mut) with a V5/HIS 
tag were transiently expressed in SH-SY5Y cells in the presence or absence of Flag-BAG1 and subjected to subcellular fractionation and immunoblotting. Both 
DJ-1 wild type and DJ-1 L166P mutant were found equally abundant in the cytosolic and membrane/organelle fractions. However, the nuclear fraction con-
tained only mutant DJ-1, whereas DJ-1 wild type was absent. Compartment-specific proteins served as loading controls (bottom). In the membrane/organelle 
fraction, we detected an extra band at 50 kD, which likely corresponds to DJ-1 homodimers. (B) Nuclear accumulation of DJ-1 mutant in situ was confirmed 
by microscopy using EGFP-tagged DJ-1. (C) Coexpression of BAG1 together with DJ-1 increases the ratio of dimer/monomer staining intensity both for wild-
type and mutant protein. Densitometry of immuno signal quantitates levels of DJ-1 protein. Error bars indicate SEM out of triplicates. Bars, 10 µm.509 BAG1 restores DJ-1 function • Deeg et al.
Discussion
DJ­1 protein mutations have been linked to recessive familial 
forms of PD. Although these cases represent only a minor portion   
of all PD cases, the majority of which are sporadic, an understand­
ing of the disease mechanisms underlying familial PD may shed 
light on the pathophysiological events that operate in sporadic PD 
as well. However, so far, no consensus on the exact function of 
DJ­1 and its role in PD could be achieved. In this study, we com­
pared the known disease mutation DJ­1 L166P with the wild­type 
protein in terms of subcellular localization, dimer formation, and 
biological activity.
Using biochemical fractionation methods, we show that 
DJ­1 wild type is present in the cytosol and mitochondrial frac­
tion. DJ­1 L166P is also present in these compartments but is 
found additionally in the nucleus. This is interesting because 
other proteins that are implicated in neurodegenerative disorders 
(e.g., huntingtin in Huntington’s disease [Saudou et al., 1998], 
ataxin­1 in SCA1 [Klement et al., 1998], and ataxin­3 in SCA3 
[Schmidt et al., 1998]) are thought to cause disease at least in 
part through their abnormal accumulation in the nucleus. How­
ever, the relevance of the nuclear localization of mutant DJ­1 
demands further investigation.
Structural investigations of DJ­1 revealed that it forms 
homodimers and that the L166P mutation impairs this dimer 
formation. Our results obtained by protein biochemistry and 
FRET microscopy in single intact cells confirm that DJ­1 wild 
type but not DJ­1 L166P has the capacity to form dimers under 
physiological conditions.
With respect to DJ­1 function, there have been several 
studies linking the protein to redox and chaperone systems, 
albeit without producing a unifying concept or conclusive 
results (Kinumi et al., 2004; Taira et al., 2004; Andres­Mateos 
et al., 2007; Batelli et al., 2008). We aimed at resolving this 
controversy in neuronal cells by the application of our fluor­
escent chaperone sensor. Indeed, we are able to show for the 
first time that DJ­1 wild type exerts a strong chaperone­like 
activity in intact single cells, which is lost in DJ­1 bearing the 
L166P mutation. From the combination of FRET/FLIM mea­
surements quantifying dimerization of fluorescently labeled 
DJ­1, we can conclude that homodimerization is a prerequisite 
for chaperone function and that the L166P mutation severely 
impairs  dimerization  capacity,  suggesting  that  this  is  the 
molecular defect that gives rise to disease pathophysiology. 
Additionally, we present BAG1, a cochaperone protein with 
previously  described  neuroprotective  functions  (Takayama   
Figure 4.  BAG1 influences DJ-1 dimerization (FRET/FLIM experiments).  
(A and B) Dimerization of DJ-1 isoforms was examined in SH-SY5Y neuro-
blastoma  cells.  Control  lifetime  distributions  were  obtained  from  cells   
expressing only the CFP-labeled DJ-1 (A and B, black trace, grayed area). 
Lifetimes were converted to FRET efficiencies using the mean lifetime of this 
condition. Coexpression of CFP- and YFP-labeled wild-type DJ-1 (wtDJ1) 
reduces the CFP lifetime, i.e., increases FRET, which is indicative of homo-
dimerization. Coexpression of BAG1 further increases the level of dimer-
ization (A, blue trace). The FRET efficiency between CFP- and YFP-labeled 
mutant DJ-1 (mDJ1) is lower (B, red trace) but restores to wild-type DJ-1 basal 
levels upon coexpression of DJ-1. The dashed line at 25% FRET indicates 
the adopted threshold value. (C) These relationships were confirmed by 
statistical analysis. FRET efficiency of different conditions (n = 15) by t test   
(***, P < 0.001); p > threshold. Error bars indicate SEM out of triplicates. 
(D) Images of the FRET efficiency, i.e., level of dimerization, in representa-
tive cells were color-coded as indicated in the activity scale. Bars, 10 µm.
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inability of the protein to form a functional homodimer, lead­
ing to anomalous nuclear targeting. Coexpression of BAG1 
corrects dimer formation and proper subcellular distribution, 
thereby ameliorating the toxic action of the DJ­1 mutant.
In summary, we linked DJ­1 subcellular localization and 
levels of dimerization to its physiological function in neuronal 
cells. Our results provide evidence in support of the view that 
DJ­1 acts, in dimeric form, as a chaperone with very strong fol­
dase activity. In fact, the folding activities achieved by DJ­1 are 
similar in magnitude to those observed upon overexpression of 
HSP70 (Liman et al., 2005; Ganesan et al., 2008). Because it is 
believed that it is the loss of DJ­1 function that underlies this ge­
netic form of PD, stimulating the cellular chaperone machinery 
could prove to be of therapeutic potential for DJ­1–dependent 
PD. Accordingly, we show that BAG1, an antiapoptotic foldase­
stimulating cochaperone, restores DJ­1 L166P dimerization and 
chaperone function. Our data add to the current understanding 
of PD pathophysiology and point toward novel putative thera­
peutic avenues.
et al., 1995; Kermer et al., 2003; Townsend et al., 2003), as 
new binding partner for DJ­1, with important consequences 
for DJ­1 function.
Strikingly, we found that BAG1 influences several pa­
rameters affected by the L166P mutation. First, it decreases the 
abundance of L166P mutant in the nuclear fraction; second, it 
stimulates dimer formation of both wild­type and L166P DJ­1; 
third, it enhances chaperone function as seen in the folding sen­
sor assay. Interestingly, even though dimerization of DJ­1 was 
reestablished by BAG1 to levels of DJ­1 wild type and BAG1 
increased the level of DJ­1 wild type even further, no additional 
increase in foldase activity was observed for DJ­1 wild type 
when coexpressed with BAG1. This seems to suggest that the 
targets of DJ­1 limit maximal stimulation under overexpres­
sion conditions.
Finally, we observed that overexpression of DJ­1 L166P 
in SH­SY5Y cells leads to an increase in cell death. Because 
it is assumed that loss of DJ­1 function causes toxicity, one 
can speculate that L166P­induced cell death is caused by the 
Figure 5.  DJ-1 possesses chaperone activity. (A–C) 
Folding activity was quantified in SH-SY5Y cells ex-
pressing different constructs in addition to the cdYFP 
foldase  sensor.  Cells  expressing  only  the  biosen-
sor serve as control and reference situation, with a 
foldase activity of unity (A, black trace with grayed 
area).  The  normalized  cumulative  distribution  (PDF) 
is shown. Expression of BAG1 increases cellular fol-
dase activity (A, green trace). Expression of wild-type 
DJ-1 (wtDJ1; B, red trace) increases foldase activity, 
and coexpression of BAG1 slightly increases foldase 
activity even further (B, dark blue trace). Correction 
of this distribution for the induction by BAG1 alone 
shows DJ-1 to be a high activity chaperone (B, light 
blue trace). Expression of mutant DJ-1 (mDJ1) does not 
induce foldase activity (C, red trace), but coexpression 
of BAG1 restores foldase activity to equal the BAG1-
enhanced wild-type DJ-1 levels (C, dark blue trace). 
Consequently, the isolated DJ-1 activity (C, light blue 
trace) is similar to that of the wild-type protein. The 
dashed line at fourfold increased folding indicates the 
adopted threshold value. (D) Statistical analysis con-
firms these relationships. Induced foldase activity of 
different conditions (n = 10) by t test (**, P < 0.01; 
***, P < 0.001); p > threshold. Error bars indicate 
SEM out of triplicates. (E) Images of the folding activity 
in representative cells, color-coded as indicated in the 
activity scale, are shown. Bars, 10 µm.511 BAG1 restores DJ-1 function • Deeg et al.
Materials and methods
Constructs and transfection conditions
Constructs used were full-length cDNA constructs for DJ-1 wild type and 
L166P mutant carrying a C-terminal V5/HIS tag or a C-terminal Flag tag, 
full-length  cDNA  constructs  for  DJ-1  wild  type  and  L166P  mutant  as  a   
C-terminal CFP or as a N-terminal YFP fusion protein, full-length cDNA con-
structs for BAG1 and BAGC with or without a C-terminal Flag tag, and 
cdYFP with an N-terminal HA tag. All constructs were verified by sequenc-
ing at Seqlab, Sequence Laboratories Göttingen GmbH.
siGenome  SMARTpool  DJ-1  siRNA  and  siGenome  nontargeting 
siRNA pool siRNA were purchased from Thermo Fisher Scientific. Cells 
were transiently transfected using Lipofectamine 2000 (Invitrogen) accord-
ing to the manufacturer’s instructions.
Preparation of protein extracts and Western blot analysis
Cells were washed, scraped in ice-cold PBS, and pelleted. Cell lysates were 
prepared using lysis buffer containing 50 mM Tris-HCl, pH 7.4, 150 mM 
NaCl, 1% Triton-X 100, and complete protease inhibitor cocktail (Roche) 
for  15  min  at  4°C,  followed  by  10-min  centrifugation  at  13,000  rpm   
at 4°C. Subcellular fractionation was performed using ProteoExtract Sub-
cellular Proteome Extraction kit (EMD).
Lysates were mixed with 6× Laemmli loading buffer and boiled for 
5 min at 95°C before performing the SDS-PAGE Western blot. Membranes 
were blocked for 1 h in 5% dried milk powder in TBST (TBS/Tween 20) at 
room temperature.
Quantitative densitometric analysis (Fig. 3 C) was performed on 
digitized images of immunoblots using the Fluor-S MultiImager (Bio-Rad 
Laboratories)  with  Quantity-One-4.2.2  software  (Bio-Rad  Laboratories). 
SEM  refers  to  triplicate  preparations  of  protein  extracts.  Densitometric   
levels of monomer and dimer fractions of DJ-1 protein were normalized to 
levels of cadherin loading control. The experiments were repeated at least 
three times using SH-SY5Y and HEK293T cells.
Coimmunoprecipitation
Cells were cultured and transfected in 6-well plates, and immunoprecipita-
tion was performed with red anti-Flag M2 affinity gel (Sigma-Aldrich). After 
bead equilibration and cell lysate preparation, samples were incubated for 
4 h at 4°C. The bead pellet was washed with TBS and centrifuged in a 
microcentrifuge (Biofuge Fresco; Heraeus) for 30 s at 8,200 g. Washing 
steps were repeated three times, and bound protein was eluted using SDS-
PAGE sample buffer. The experiments were repeated at least three times 
using SH-SY5Y and HEK293T cells.
Immunocytochemistry
Cells cultured on coverslips and transfected with the biosensor HA-cdYFP 
for the chaperone assay were washed in PBS and fixed in PBS containing 
4% PFA for 10 min at room temperature, followed by several washing 
steps in PBS. Permeabilization was performed with 0.1% Triton X-100 in 
PBS for 10 min with subsequent preblocking in PBS containing 3% bovine   
serum albumin. Cells were incubated in blocking solution containing   
anti-HA antibody (1:1,000 dilution; Covance) for 1 h at room temperature. 
After washing three times in PBST (PBS Tween 20) and incubation with   
Cy5-conjugated  secondary  antibody  (1:400  dilution;  Jackson  Immuno-
Research Laboratories, Inc.) for 1 h at room temperature, cells were again 
washed  three  times  in  PBST  and  mounted  on  microscope  slides  using   
Roti-Histokitt 2 (Roth) imaging medium.
Cells cultured on coverslips and transfected with CFP–DJ-1 wild-type 
or mutant protein were washed in PBS and fixed in PBS containing 4% 
PFA for 10 min at room temperature, followed by several washing steps in 
PBS. Permeabilization was performed with 0.1% Triton X-100 in PBS for 
10 min with subsequent preblocking in PBS containing 3% bovine serum 
albumin. Cells were incubated in blocking solution containing anti-BAG1 
antibody (rabbit polyclonal BAG 1680; 1:1,000 dilution) for 1 h at room 
temperature. After washing three times in PBST and incubation with Cy5-
conjugated secondary antibody (1:400 dilution; Jackson ImmunoResearch 
Laboratories, Inc.) for 1 h at room temperature, cells were again washed 
three times in PBST. Slides were stained with DAPI to detect nuclei. Roti-
Histokitt 2 imaging medium was used.
Figure 6.  BAG1 prevents DJ-1 L166P–induced cell death. (A) Transient 
cotransfection of SH-SY5Y cells with fluorescently tagged DJ-1 (either wild 
type [WT] or L166P [Mut]) and BAG1 or empty vector. Cell count was 
based on DAPI staining, and cells presenting fragmented and pyknotic 
nuclei were considered apoptotic. Comparison of cell count of different 
conditions (n = 2,000) by t test (**, P < 0.0001) is shown. (B) We con-
firmed these findings in SH-SY5Y and HEK293T cells by measuring the 
release of adenylate kinase from damaged cells with the help of a bio-
luminescent cytotoxicity assay. Expression of the BAGC deletion mutant 
does not ameliorate DJ-1 mutant toxicity. The amount of cell death within 
conditions compared by t test (**, P < 0.0001) is shown. (A and B) Error 
bars indicate SEM out of triplicates. Bar, 10 µm.
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release of adenylate kinase from damaged cells. Cells were cultured in 
6-well plates, and 36 h after transfection, cell supernatant was transferred 
to a luminescence-compatible 96-well plate. Analysis was performed with 
a microplate luminometer (Trilux Microbeta 1450; Wallac).
Transient cotransfection of SH-SY5Y cells was performed with fluor-
escently tagged DJ-1 (either wild type or L166P) and BAG1 or empty vec-
tor. Cells cultured on coverslips and transfected with CFP–DJ-1 wild type 
or mutant protein were washed in PBS and fixed in PBS containing 4% 
PFA for 10 min at room temperature, followed by several washing steps in 
PBS. Permeabilization was performed with 0.1% Triton X-100 in PBS for 
10 min with subsequent preblocking in PBS containing 3% bovine serum 
albumin. Cells were incubated in blocking solution containing anti-BAG1 
antibody (rabbit polyclonal BAG 1680; 1:1,000 dilution) for 1 h at room 
temperature. After washing three times in PBST and incubation with Cy5-
conjugated secondary antibody (1:400 dilution; Jackson ImmunoResearch 
Laboratories, Inc.) for 1 h at room temperature, cells were again washed 
three times in PBST. Slides were stained with DAPI to detect nuclei. Roti-
Histokitt 2 imaging medium was used.
Wide-field fluorescent images were obtained at room temperature 
using an Axioplan2 microscope equipped with a 63× NA 1.4 oil objec-
tive. The camera used was an AxioCam, and Axiovision was used as 
acquisition software. Cell counts were based on DAPI staining, and cells 
presenting fragmented and pyknotic nuclei were considered apoptotic. Up 
to 2,000 cells per condition were counted, and experiments were repeated 
at least three times using SH-SY5Y and CSM 14.1 cells.
Antibodies
The following antibodies were used at corresponding dilutions: 1:1,000 rabbit 
polyclonal BAG 1680, 1:1,000 HA (Covance), 1:1,000 goat polyclonal DJ-1   
(Imgenex), 1:1,000 mouse monoclonal -tubulin (Sigma-Aldrich), 1:2,000 
mouse histone 2B (Abcam), 1:5,000 mouse actin (Millipore), 1:1,000 rab-
bit HSP70 (Sigma-Aldrich), 1:2,000 mouse cadherin (Sigma-Aldrich), and 
1:2,000 mouse vimentin (Sigma-Aldrich).
Cell culture
CSM 14.1 wild-type cells were grown in DME supplemented with 10% 
FCS and penicillin/streptomycin at 32°C. SH-SY5Y and HEK293T cells 
were grown in DME supplemented with 10% FCS and penicillin/strepto-
mycin at 37°C. For transient transfections, Lipofectamine 2000 was used.
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